Publications

Export 184 results:
Sort by: Author Title Type [ Year (Desc)]
2012
Wiersma, S. T., B. McMahon, J. M. Pawlotsky, C. L. Thio, M. Thursz, S. G. Lim, P. Ocama, G. Esmat, M. Mendy, D. Bell et al. "Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus (vol 31, pg 755, 2011)." LIVER INTERNATIONAL 32 (2012): 174. Abstract
n/a
Esmat, G., M. El Raziky, M. El Kassas, M. Hassany, and M. E. Gamil. "The future for the treatment of genotype 4 chronic hepatitis C." LIVER INTERNATIONAL 32 (2012): 146-150. Abstract
n/a
El-Shamy, Ahmed, Ikuo Shoji, Wafaa El-Akel, Shymaa E. Bilasy, Lin Deng, Maissa El-Raziky, Da-peng Jiang, Gamal Esmat, and Hak Hotta. "NS5A Sequence Heterogeneity of Hepatitis C Virus Genotype 4a Predicts Clinical Outcome of Pegylated-Interferon-Ribavirin Therapy in Egyptian Patients." JOURNAL OF CLINICAL MICROBIOLOGY 50 (2012): 3886-3892. Abstract
n/a
Fawzy, I. O., M. Negm, R. Ahmed, G. Esmat, N. Hamdi, and A. I. Abdelaziz. "Tamoxifen alleviates hepatitis C virus-induced inhibition of both toll-like receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females." JOURNAL OF VIRAL HEPATITIS 19 (2012): 854-861. Abstract
n/a
Abbas, Emad, Olfat Shaker, Ghada Abd El Aziz, Huda Ramadan, and Gamal Esmat. "Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study." EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24 (2012): 458-463. Abstract
n/a
Elsharkawy, A., G. Esmat, M. El Raziky, W. Elakel, M. Abdel-Rahman, and M. Elsayed. "HCV/SCHISTOSOMIASIS COINFECTION: IMPACT ON FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN THERAPY." JOURNAL OF HEPATOLOGY 56 (2012): S61. Abstract
n/a
Yosry, Ayman, Mohamed Said, Gamal Esmat, Magdy Al-Serafy, Ashraf Omar, Wahid Doss, Dalia Omran, Yasmin Saad, Sanna Kamel, Akram Abdel-Bary et al. "HLA Tissue Typing Has No Effect on the Outcome of Patients Undergoing a Living-donor Liver Transplant: A Single-center Experience in Egypt." EXPERIMENTAL AND CLINICAL TRANSPLANTATION 10 (2012): 136-140. Abstract
n/a
El Tayebi, H. M., K. A. Hosny, G. Esmat, K. Breuhahn, and A. I. Abdelaziz. "MIR-155 IS AN INDUCER FOR THE INSULIN-LIKE GROWTH FACTOR II MITOGENIC SIGNALING PATHWAY IN HCV-PROGRESSED HEPATOCELLULAR CARCINOMA." JOURNAL OF HEPATOLOGY 56 (2012): S112. Abstract
n/a
ElHefnawi, Mahmoud, Mahmoud Abdalla, Safaa Ahmed, Wafaa elakel, Gamal Esmat, Maissa El Raziky, Shaima Khamis, and Marwa Hassan. "Accurate prediction of response to Interferon-based therapy in Egyptian patients with Chronic Hepatitis C using machine-learning approaches." In 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), 771-778., 2012. Abstract
n/a
Maher, Mohsen M., Sayed M. Shalaby, Gamal Esmat, Mohamed Abd El Adl Al-Sawey, Manal Zaghloul Maharan, Tarek M. Yosef, Wesam A. Ibrahim, Naglaa Zayed, Nesrine A. Mohamed, and Sarah Abdel Kader El-Nakeep. "Light Chain Antigenic Determinants (kappa and gamma) Influence on the Treatment Outcome of Chronic Hepatitis C Infection in Egypt." LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION 9 (2012): 2329-2333. Abstract
n/a
Hamdi, N., W. El-Akel, M. El-Serafy, G. Esmat, C. Sarrazin, and A. I. Abdelaziz. "Transcriptional Response of MxA, PKR and SOCS3 to Interferon-Based Therapy in HCV Genotype 4-Infected Patients and Contribution of p53 to Host Antiviral Response." INTERVIROLOGY 55 (2012): 210-218. Abstract
n/a
2011
Hatzakis, A., S. Wait, J. Bruix, M. Buti, M. Carballo, M. Cavaleri, M. Colombo, E. Delarocque-Astagneau, G. Dusheiko, G. Esmat et al. "The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference." JOURNAL OF VIRAL HEPATITIS 18 (2011): 1-16. Abstract
n/a
Hezode, Christophe, Gideon M. Hirschfield, Wayne Ghesquiere, William Sievert, Maribel Rodriguez-Torres, Stephen D. Shafran, Paul J. Thuluvath, Harvey A. Tatum, Imam Waked, Gamal E. Esmat et al. "BMS-790052, A NS5A REPLICATION COMPLEX INHIBITOR, COMBINED WITH PEGINTERFERON ALFA-2A AND RIBIVIRIN IN TREATMENT-NAIVE HCV-GENO-TYPE 1 OR 4 PATIENTS: PHASE 2B AI444010 STUDY INTERIM WEEK 12 RESULTS." HEPATOLOGY 54 (2011): 474A-475A. Abstract
n/a
Ashour, Mohamed K., Maissa E. Elraziky, Wafaa A. ElAkel, Amr Eldeeb, Mohamed Abdel-Hamid, Sherif El Kafrawy, Hani M. Khattab, and Gamal E. Esmat. "SAFETY, DOSAGE AND EFFICACY OF A NOVEL Y SHAPED MOLECULE OF PEGYLATED INTERFERON ALPHA 2A FOR TREATMENT OF CHRONIC HCV." HEPATOLOGY 54 (2011): 1006A. Abstract
n/a
Zakhari, Samir, Gamal Esmat, and Scott Friedman. "Introduction to the Symposium." ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 35 (2011): 775. Abstract
n/a
El Awady, Mostafa K., Mohamed A. Anany, Gamal Esmat, Naglaa Zayed, Ashraf A. Tabll, Amr Helmy, Abdel Rahman El Zayady, Mohga S. Abdalla, Hayat M. Sharada, Maissa El Raziky et al. "Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy." JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26 (2011): 843-850. Abstract
n/a
Hashem, Mohamed, Hanaa El-Karaksy, Mohamed T. Shata, Maha Sobhy, Heba Helmy, Suzan El-Naghi, Gehan Galal, Zainab Z. Ali, Gamal Esmat, Sayed F. Abdelwahab et al. "Strong Hepatitis C Virus (HCV)-specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children." JOURNAL OF INFECTIOUS DISEASES 203 (2011): 854-861. Abstract
n/a
El Tayebi, H. M., W. Salah, I. H. El Sayed, E. M. Salam, A. R. N. Zekri, N. Zayed, E. S. Salem, G. Esmat, and A. I. Abdelaziz. "Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients." BIOMARKERS 16 (2011): 346-354. Abstract
n/a
Elhawary, Eman I., Gamal F. Mahmoud, Mai A. El-Daly, Fatma A. Mekky, Gamal G. Esmat, and Mohamed Abdel-Hamid. "Association of HCV with diabetes mellitus: an Egyptian case-control study." VIROLOGY JOURNAL 8 (2011). Abstract
n/a
Vignier, N., G. Esmat, A. Elsharkawy, M. Hassany, P. Bonnard, E. Delarocque-Astagneau, M. Said, R. Raafat, M. El-Hoseiny, A. Fontanet et al. "Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt." JOURNAL OF VIRAL HEPATITIS 18 (2011): E358-E365. Abstract
n/a
Sievert, William, Ibrahim Altraif, Homie A. Razavi, Ayman Abdo, Ezzat Ali Ahmed, Ahmed AlOmair, Deepak Amarapurkar, Chien-Hung Chen, Xiaoguang Dou, Hisham El Khayat et al. "A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt." LIVER INTERNATIONAL 31 (2011): 61-80. Abstract
n/a
El Din, Noha Bader G., Mai Abd El Meguid, Ashraf A. Tabll, Mohamed A. Anany, Gamal Esmat, Naglaa Zayed, Amr Helmy, Abdel Rahman El Zayady, Ahmed Barakat, and Mostafa K. El Awady. "Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy." JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26 (2011): 55-62. Abstract
n/a
2010
El-Karaksy, Hanaa Mostafa, Ghada Anwar, Gamal Esmat, Samah Mansour, Magda Sabry, Heba Helmy, Ahmad El-Hennawy, and Hanan Fouad. "Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus." PEDIATRIC DIABETES 11 (2010): 462-470. Abstract
n/a
Fathy, Amal, Mohamed Mohy Eldin, Lobna Metwally, Mohamed Eida, Marwa Abdel-Rehim, and Gamal Esmat. "Interferon therapy shifts natural killer subsets among Egyptian patients with chronic hepatitis C." BRAZILIAN JOURNAL OF INFECTIOUS DISEASES 14 (2010): 398-405. Abstract
n/a
El Garem, H., El Deen G. Esmat, O. Shaker, M. Mohaned, A. Salama, and A. Abolfotoh. "Evaluation of serum TIMP-1 & TGF-beta 1 in Egyptian patients with chronic hepatitis C, genotype 4 & chronic hepatitis B infection." INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 14 (2010): S71. Abstract
n/a
Tourism